Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20:1366–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weiss SA, Wolchok JD, Sznol M. Immunotherapy of Melanoma: facts and hopes. Clin Cancer Res. 2019;25:5191–201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christodoulou E, Rashid M, Pacini C, Droop A, Robertson H, van Groningen T, et al. Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma. Pigment Cell Melanoma Res. 2021;34:122–31.

Article  CAS  PubMed  Google Scholar 

Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus Ipilimumab in Advanced Melanoma. N Engl J Med. 2015;372:2521–32.

Article  CAS  PubMed  Google Scholar 

Noman MZ, Hasmim M, Lequeux A, Xiao M, Duhem C, Chouaib S, et al. Improving Cancer Immunotherapy by targeting the hypoxic Tumor Microenvironment: New opportunities and challenges. Cells. 2019;8:1083.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to Cancer. Annu Rev Immunol. 2011;29:235–71.

Article  CAS  PubMed  Google Scholar 

Mertowski S, Grywalska E, Gosik K, Smarz-Widelska I, Hymos A, Dworacki G, et al. TLR2 expression on select lymphocyte subsets as a new marker in Glomerulonephritis. J Clin Med. 2020;9:541.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park H-J, Ko HL, Won D-H, Hwang D-B, Shin Y-S, Kwak H-W, et al. Comprehensive Analysis of the Safety Profile of a single-stranded RNA Nano-structure adjuvant. Pharmaceutics. 2019;11:464.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2001;2:947–50.

Article  CAS  PubMed  Google Scholar 

Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V. Toll-like receptors control autophagy. EMBO J. 2008;27:1110–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smits ELJM, Ponsaerts P, Berneman ZN, Van Tendeloo VFI. The Use of TLR7 and TLR8 ligands for the enhancement of Cancer Immunotherapy. Oncologist. 2008;13:859–75.

Article  CAS  PubMed  Google Scholar 

Kobold S, Wiedemann G, Rothenfußer S, Endres S. Modes of action of TLR7 agonists in cancer therapy. Immunotherapy. 2014;6:1085–95.

Article  CAS  PubMed  Google Scholar 

Wang W, Liu Z, Niu J, Yang H, Long Q, Liu H, et al. Feibi recipe reduced Pulmonary Fibrosis Induced by Bleomycin in mice by regulating BRP39/IL-17 and TGFβ1/Smad3 Signal pathways. Evidence-Based Complement Altern Med. 2020;2020:1–13.

Google Scholar 

Hou C, Zhou D-H, Wu Y-J, Dai X-J, Wang Q-Y, Wu Y-Q, et al. In Vitro and in vivo inhibitory effect of Gujin Xiaoliu Tang in Non-small Cell Lung Cancer. Evidence-Based Complement Altern Med. 2018;2018:1–14.

Article  Google Scholar 

Efferth T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Sem Cancer Biol. 2017;46:65–83.

Article  CAS  Google Scholar 

Li YJ, Zhou JH, Du XX, Jia DX, Wu CL, Huang P, et al. Dihydroartemisinin Accentuates the Anti-Tumor Effects of Photodynamic Therapy via Inactivation of NF-κB in Eca109 and Ec9706 Esophageal Cancer Cells. Cell Physiol Biochem. 2014;33:1527–36.

Wang S-J, Gao Y, Chen H, Kong R, Jiang H-C, Pan S-H, et al. Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett. 2010;293:99–108.

Article  CAS  PubMed  Google Scholar 

Kim SJ, Kim MS, Lee JW, Lee CH, Yoo H, Shin SH, et al. Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro. J Cancer Res Clin Oncol. 2006;132:129–35.

Article  CAS  PubMed  Google Scholar 

Li X, Ba Q, Liu Y, Yue Q, Chen P, Li J, et al. Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein. Cell Discov. 2017;3:17042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin L-T, Wu S-J, Lin C-C. The Anticancer properties and apoptosis-inducing mechanisms of Cinnamaldehyde and the Herbal prescription Huang-Lian-Jie-Du-Tang (黃連解毒湯 Huáng Lián Jiě Dú Tang) in human hepatoma cells. J Traditional Complement Med. 2013;3:227–33.

Article  CAS  Google Scholar 

Wang N, Feng Y, Tan H-Y, Cheung F, Hong M, Lao L, et al. Inhibition of eukaryotic elongation factor-2 confers to tumor suppression by a herbal formulation Huanglian-Jiedu decoction in human hepatocellular carcinoma. J Ethnopharmacol. 2015;164:309–18.

Article  CAS  PubMed  Google Scholar 

Zhang H, Fu P, Ke B, Wang S, Li M, Han L, et al. Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang. J Ethnopharmacol. 2014;154:55–64.

Article  PubMed  Google Scholar 

Wang P-R, Wang J-S, Zhang C, Song X-F, Tian N, Kong L-Y. Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway. J Ethnopharmacol. 2013;149:270–80.

Article  PubMed  Google Scholar 

Zhang Q, Bian H, Li Y, Guo L, Tang Y, Zhu H. Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats. J Ethnopharmacol. 2014;154:443–52.

Article  PubMed  Google Scholar 

Yi Q, He X-E, Luo K-F, Zhang G-S, Liu Y-H, Xue Q, et al. Protection of Long-Term Treatment with Huang-Lian-Jie-Du-Tang on vascular endothelium in rats with type 2 diabetes Mellitus. Curr Therapeutic Res. 2012;73:174–85.

Article  Google Scholar 

Zhang X-J, Deng Y-X, Shi Q-Z, He M-Y, Chen B, Qiu X-M. Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism. Phytomedicine. 2014;21:615–23.

Article  CAS  PubMed  Google Scholar 

Chen Y, Xian Y, Lai Z, Loo S, Chan WY, Lin Z-X. Anti-inflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: implication for atopic dermatitis treatment. J Ethnopharmacol. 2016;185:41–52.

Article  PubMed  Google Scholar 

Ren W, Zuo R, Wang Y-N, Wang H-J, Yang J, Xin S-K, et al. Pharmacokinetic-pharmacodynamic analysis on inflammation rat model after oral administration of Huang Lian Jie Du Decoction. PLoS ONE. 2016;11:e0156256.

Article  PubMed  PubMed Central  Google Scholar 

Liu S, Yang Q, Dong B, Qi C, Yang T, Li M, et al. Gypenosides Attenuate Pulmonary Fibrosis by inhibiting the AKT/mTOR/c-Myc pathway. Front Pharmacol. 2021;12:806312.

Article  CAS  PubMed  Google Scholar 

He S, Wang S, Liu S, Li Z, Liu X, Wu J. Baicalein Potentiated M1 Macrophage polarization in Cancer through Targeting PI3Kγ/ NF-κB signaling. Front Pharmacol. 2021;12:743837.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Q, Sun J, Cao Y, Liu B, Li L, Mohammadtursun N, et al. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis. Biomed Pharmacother. 2020;123:109735.

Article  CAS  PubMed  Google Scholar 

Bejarano L, Jordāo MJC, Joyce JA. Therapeutic targeting of the Tumor Microenvironment. Cancer Discov. 2021;11:933–59.

Article  CAS  PubMed  Google Scholar 

Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, et al. X-linked recessive TLR7 deficiency in ~ 1% of men under 60 years old with life-threatening COVID-19. Sci Immunol. 2021;6:eabl4348.

Article  PubMed  PubMed Central  Google Scholar 

Murayama G, Furusawa N, Chiba A, Yamaji K, Tamura N, Miyake S. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther. 2017;19:234.

Article  PubMed  PubMed Central  Google Scholar 

Dai J-P, Wang Q-W, Su Y, Gu L-M, Zhao Y, Chen X-X, et al. Emodin Inhibition of Influenza A Virus replication and influenza viral pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB pathways. Molecules. 2017;22:1754.

Article  PubMed  PubMed Central  Google Scholar 

Jablonowska E, Wojcik K, Nocun M. The influence of treatment with Pegylated Interferon-Alfa and Ribavirin on Neutrophil function and death in patients with HIV/HCV Coinfection. Viral Immunol. 2012;25:166–72.

Article  CAS